EXEL
Exelixis, Inc. · Healthcare
Director Stelios Papadopoulos sold $1.2M of Exelixis, Inc.
Sold$1,162,800
$25.84Price
45,000Shares
−4%Stake
What EXEL did after the filing
Prices for EXEL after this filing aren't in yet.
Traded Fri, May 8. Filed Fri, May 8, 9:18 PM ET, after the close. Not investment advice.